Breast Neoplasms: all 12,828 studies
Page 73 of 129. Open to participants first (2,932), then studies with results posted, then the rest; newest registration first within each.
- No Axillary sUrgical Treatment In Clinically Lymph Node Negative Patients After UltraSonographyActive, not recruitingNCT04303715Not applicable
- Effects of the Anchor System in the Postural StabilityStatus unknownNCT04303221Not applicable
- Metabolomics Explores Biomarkers for Metastatic Breast CancerStatus unknownNCT04302415
- Study to Evaluate the Effect of Metformin in the Prevention of HG in HR[+]/HER2[-] PIK3CA-mut Advanced BC PatientsCompletedNCT04300790Phase 2
- Appetite and Exercise in Breast Cancer SurvivorsCompletedNCT04300478Not applicable
- Pre-operative Hypnosis to Prevent Side Effects After SurgeryCompletedNCT04300283Not applicable
- Dose-finding Study of BP-C1 in Patients With Stage IV Breast CancerCompletedNCT04298333Phase 1
- A Study of the Body's Response to Exercise and a Plant-Based Diet in Overweight Postmenopausal Women With Breast CancerActive, not recruitingNCT04298086Phase 2
- Using BETTER Model Sexual Problems in Breast CancerCompletedNCT04297657Not applicable
- Breast Cancer Pathways Program Impact on Patient Shared Decision Making and Experience in Academic and Community PracticeCompletedNCT04297384Not applicable
- A Study to Evaluate Gemcitabine Plus Cisplatin in the Treatment of TNBC Patients Following Neoadjuvant ChemotherapyStatus unknownNCT04297267Phase 2
- Pectoral Nerve Block Type-II and Rhomboid Intercostal Block for Pain Management Following Mastectomy SurgeryCompletedNCT04297007Not applicable
- The Effect of Complex Decongestive Physiotherapy on Sensory Parameters in Breast Cancer Related Lymphedema.Status unknownNCT04296929Not applicable
- Carboplatin Intensified Chemotherapy for TRIple NEgative Breast Cancer(CITRINE)Active, not recruitingNCT04296175Phase 3
- Oral Vinorelbine or Capecitabine Combined With Trastuzumab as Adjuvant Treatment for Patients With Lymph Node Negative, HER-2 Positive and Small Tumor Size Breast Cancer (ORCHID)CompletedNCT04296162Phase 2
- Adaptive Symptom Care Using Fish-Based Nutritional Directives Post Breast CancerCompletedNCT04293874Not applicable
- Study to Evaluate the Efficacy and Safety of SHR6390 Combined With Pyrotinib in HER2+ Advanced Breast CancerStatus unknownNCT04293276Phase 2
- LCCC1931:Post-treatment Intervention in Women With Breast Cancer (70y/o+)CompletedNCT04292847
- BIOPSY SCANNER LLTECH© Technology for Diagnosis of Breast CancerCompletedNCT04292821
- Epigenetics of TNBC in Overweight and Obese Hispanic & Non-Hispanic White WomenWithdrawnNCT04291950
- Oxaloacetate for the Improvement of Cognitive Complaints in Stage 0-IIIA Breast Cancer SurvivorsCompletedNCT04290897Phase 2
- Neoadjuvant Chemotherapy With Pyrotinib, Epirubicin and Cyclophosphamide Followed by Taxanes and Trastuzumab for HER-2+ Breast CancerActive, not recruitingNCT04290793Phase 2/3
- Technology and Health Communication in Improving Health Outcomes in Patients Scheduled for MammographyCompletedNCT04290585Not applicable
- Predicted Biomarkers of CDK4/6 Inhibitors (Palbociclib) in ER-positive Metastasis Breast CancerStatus unknownNCT04289974
- Integrin α6-targeted SPECT Imaging of Breast CancerCompletedNCT04289532Early Phase 1
- A Study to Measure the Expression of the HER2-HER3 Dimer in Tumour and Blood (Exosomes) Samples From Patients With HER2 Positive Breast Cancer Receiving HER2 Targeted TherapiesStatus unknownNCT04288141
- Individualized Locoregional Treatment of Initially Biopsy-proven Node-positive Breast Cancer After Primary Systemic TherapyWithdrawnNCT04281355Phase 3
- Phase II Study of FTD/TPI (Lonsurf) in Metastatic Breast Cancers With or Without Prior Exposure to Fluoropyrimidines (LONBRECA)Active, not recruitingNCT04280536Phase 1/2
- A First-in-human Study Using BDC-1001 as a Single Agent and in Combination With Nivolumab in Advanced HER2-Expressing Solid TumorsTerminatedNCT04278144Phase 1/2
- Molecular Imaging of HER2 Expression in Breast Cancer Using 99mTc-HE3-G3CompletedNCT04277338Phase 1
- Developing a Diagnostic Tool to Predict Response to ChemotherapyStatus unknownNCT04277195
- Phase-II Study of Lu177DOTATOC in Adults With STTR(+)Pulmonary, Pheochromocytoma, Paraganglioma, Unknown Primary, Thymus NETs (PUTNET), or Any Other Non-.GEP-NET.WithdrawnNCT04276597Phase 2
- Genetic Characteristics of HER2 Positive Breast Cancer With Neoadjuvant TCHP ChemotherapyStatus unknownNCT04276337
- D4 Choline Breast PET/CTCompletedNCT04276272
- Ketamine Versus Magnesium Sulphate as Adjuvants for ESPB in Breast Cancer SurgeryCompletedNCT04275661Phase 2
- Sentinel Lymph Node Biopsy With Hybrid Technique in Breast CancerStatus unknownNCT04274946Not applicable
- A Study to Evaluate the Safety and Tolerability of Venetoclax Tablets in Combination With Capecitabine Tablets in Adult Participants With Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer Who Had Disease Progression During or After CDK4/6 Inhibitor TherapyTerminatedNCT04274933Phase 1
- Interest of Broadband Spectroscopy Analysis by Infrared Laser on Liquid Biopsies in Breast Cancer ScreeningActive, not recruitingNCT04273542Not applicable
- Breast Reconstruction With Autologous Tissue: Microsurgery or Fat Grafting?CompletedNCT04273464Not applicable
- Cancer Peptides Plus GM-CSF and Adjuvant in Breast CancerActive, not recruitingNCT04270149Phase 1
- Feasibility of Total Mastectomy in Ambulatory CareCompletedNCT04270136Not applicable
- An EORTC Study Updating the QLQ-BR23 to BR45CompletedNCT04270123
- Using Deep Learning Methods to Analyze Automated Breast Ultrasound and Hand-held Ultrasound Images, to Establish a Diagnosis, Therapy Assessment and Prognosis Prediction Model of Breast Cancer.Status unknownNCT04270032
- A Pilot Tele-rehabilitation Trial for Breast Cancer SurvivorsStatus unknownNCT04269967
- Bisphenol and Phthalate Exposures in Triple Negative Breast CancerWithdrawnNCT04268693
- 99mTc-HPArk2 SPECT/CT for the Detection of HER2-positive Breast CancerCompletedNCT04267900Early Phase 1
- Family-Based Intervention Study of the Effects of Environmental Exposures on Breast Tissue CompositionCompletedNCT04265547Not applicable
- Vinorelbine, Cisplatin, Disulfiram and Copper in CTC_EMT Positive Refractory Metastatic Breast Cancer.WithdrawnNCT04265274Phase 2
- Correlation Between Molecular Typing and Neoadjuvant Chemotherapy in Breast Cancer Patients Based on Mammaprint/Blueprint TestStatus unknownNCT04264468
- A Study to Evaluate the Efficacy and Safety of Margetuximab Plus Chemotherapy in the Treatment of Chinese Patients With HER2+ MBCActive, not recruitingNCT04262804Phase 2
- Feasibility of Integrating the Outcomes4Me Smartphone Navigation Application Into the Care Management of Breast Cancer PatientsStatus unknownNCT04262518Not applicable
- Safety, Pharmacodynamics, Pharmacokinetics, and Efficacy of Tomivosertib Combined With Paclitaxel in Advanced Breast CancerCompletedNCT04261218Phase 1
- Study Comparing Lymphoseek® vs. Albumin Nanocolloid in Head and Neck, Melanoma and Breast CancerStatus unknownNCT04261179Phase 4
- FALSE POSITIVE FINDINGS IN BREAST CANCER TOMOSYNTHESISCompletedNCT04259866
- Onco-primary Care Networking to Support TEAM-based CareActive, not recruitingNCT04258813Not applicable
- Genetic Characteristics of Metastatic Breast Cancer PatientsStatus unknownNCT04258735Not applicable
- Association of Survival With Maintenance Therapy in Patients With Metastatic Breast Cancer After First-line ChemotherapyCompletedNCT04258163
- Promoting Earlier Detection of Breast Cancer in Rwanda: Scaleup in the National Health Care SystemCompletedNCT04258085
- Aquatic Versus Land Based Exercise on Lymphedema Post MastectomyCompletedNCT04257643Not applicable
- Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their RelativesCompletedNCT04257045
- Pyrotinib in Breast Cancer Patients With Poor Response to the Neoadjuvant Treatment of Trastuzumab and PertuzumabStatus unknownNCT04255056Phase 2
- Ipatasertib + Pertuzumab +Trastuzumab in Advanced HER2+ PI3KCA-mutant Breast Cancer PatientsCompletedNCT04253561Phase 1
- A Study in Hormone Receptor-positive Metastatic Breast Carcinoma Patients to Test a New Schedule of Efti (IMP321, Eftilagimod Alpha) as Adjunctive to a Weekly Treatment Regimen of PaclitaxelWithdrawnNCT04252768Phase 1
- VR Ultrasound Guided Breast LocalizationCompletedNCT04251507Not applicable
- Predicting Response of Metastatic Triple Negative Breast Cancer to Immunotherapy Based on Patients Cytokine ProfileSuspendedNCT04250818
- Preoperative Systemic Therapy vs Upfront Surgery in HER2 Positive Early Breast CancerCompletedNCT04249440
- Cryoablation, Atezolizumab/Nab-paclitaxel for Locally Advanced or Metastatic Triple Negative Breast CancerWithdrawnNCT04249167Early Phase 1
- Calorie Restriction With or Without Metformin in Triple Negative Breast CancerStatus unknownNCT04248998Phase 2
- High Risk ER+HER2- T1-2N0-1 Early Breast Cancer With Palbociclib Plus Endocrine Therapy(HIPEx)Status unknownNCT04247633Phase 2
- Τreatment Standards and Outcomes of Patients With ER/PR Positive, HER2-negative Metastatic Breast CancerStatus unknownNCT04247035
- Concordance of the IHC4 Score Performed in Local or Central Laboratory to Endopredict in ER+/HER2- Breast CancerCompletedNCT04246606
- Capecitabine Plus Pyrotinib Versus Capecitabine Plus Trastuzumab and Pertuzumab in the First-line Treatment of HER2-positive Metastatic Breast CancerStatus unknownNCT04246502Phase 2
- Factors Affecting Functionality in Breast Cancer SurvivorsCompletedNCT04245657
- Genetic Testing for All Breast Cancer Patients (GET FACTS)CompletedNCT04245176Not applicable
- Assessing the Impact of the Microbiome on Breast Cancer Radiotherapy ToxicityCompletedNCT04245150
- A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid MalignanciesTerminatedNCT04244552Phase 1
- Concordance Between Liquid and Tissue BiopsyStatus unknownNCT04241237
- Radiation Therapy for ypN0 Breast CancerStatus unknownNCT04240548Phase 3
- Niraparib Plus Aromatase Inhibitors for Luminal-like(HER2-,ER+) and gBRCA or HDR+ Metastatic Breast Cancer (LUZERN)CompletedNCT04240106Phase 2
- Detection of Circulating Tumor Cells in Breast Cancer Patients Using a Novel Microfluidic and Raman Spectrum DeviceStatus unknownNCT04239105
- Post Mastectomy Pain Syndrome After Preoperative Stellate Ganglion Block for Breast Cancer SurgeriesStatus unknownNCT04238377Not applicable
- A Study of Neoadjuvant SHR6390 in Combination With Anastrozole, Pyrotinib, and Trastuzumab in Patients With ER+/HER2+ Breast Cancer.Status unknownNCT04236310Phase 2
- Feasibility Study of an Adapted and Supported Water Polo Program to Reduce Fatigue Related to Cancer and Improve Psychological and Social Recovery in Patients With Breast Cancer RemissionStatus unknownNCT04235946Not applicable
- Myofascial Massage for Pain and Immobility Following Breast Cancer SurgeryCompletedNCT04233385Not applicable
- Feasibility and Effectiveness of a Sleep Hygiene Education Program for Sleep Issues in Breast Cancer SurvivorsWithdrawnNCT04232319Not applicable
- Hypofractionated LocoRegional Radiotherapy in Breast CancerActive, not recruitingNCT04228991Phase 3
- E-monitoring of Patients Under Adjuvant Hormonotherapy for Breast Cancer.CompletedNCT04228432Not applicable
- Aspects of Breast-conserving SurgeryCompletedNCT04227613
- Bringing of PET-TDM FDG in the Determination of the Characteristics of Primary Mammary Tumors TrIple NegativesStatus unknownNCT04226222
- Theory-based Training to Promote Breast Cancer ScreeningCompletedNCT04225741Not applicable
- Physical Rehabilitation Evaluation and Optimal Physical Therapy (PRE-OPT)CompletedNCT04225572Not applicable
- Phase II Study of Neoadjuvant Weekly Paclitaxel and Carboplatin Followed by Dose Dense Epirubicin and Cyclophosphamide in Stage II and III Triple Negative Breast CancerCompletedNCT04224922Phase 2
- Liquid Biopsies and Imaging in Breast CancerCompletedNCT04223492Not applicable
- 89Zr-atezolizumab PET Scan and Lobular Breast CancerTerminatedNCT04222426Not applicable
- CIMER: Combined Immunotherapies in Metastatic ER+ Breast CancerWithdrawnNCT04220476Phase 2
- Effectiveness of Character Strengths-based Intervention Among Breast Cancer PatientsCompletedNCT04219267Not applicable
- Clinical Classification of Pain in Breast Cancer SurvivorsCompletedNCT04219072
- Transcutaneous Breast Cancer Diagnosis by Canine OdorologyCompletedNCT04217109Not applicable
- A Study of the Use of Text Message Reminders to Take PalbociclibActive, not recruitingNCT04216576Not applicable
- Nail Changes Associated With Chemotherapy and Prevention of Nail Pigmentation by Ice Water ImmersionStatus unknownNCT04215744Not applicable